Scientists reveal the mechanism of liquid-liquid phase separation of SARS-CoV-2 nucleocapsid

A team of scientists from the United States has recently revealed how interactions between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.


Cellular macromolecules undergo liquid-liquid phase separation to condense and form droplets that are known to facilitate many cellular functions. During the viral lifecycle, many viral proteins and nucleic acids are known to undergo liquid-liquid phase separation to support vital functions, including replication.

To reduce chemical complexity and get new information about the viral liquid-liquid phase separation process, many viral models have been developed that involve one genomic nucleic acid and one protein to promote liquid-liquid phase separation.

Regarding SARS-CoV-2 nucleocapsid, it is known that the protein exhibits lower critical solution temperature (LCST) behavior and that viral RNA regulates the temperature at which nucleocapsid undergo liquid-liquid phase separation.

In the current study, the scientists have modified the RNA sequence and structure to decipher RNA characteristics that specify liquid-liquid phase separation for SARS-CoV-2 nucleocapsid protein and genomic RNA. Specifically, they have investigated how viral nucleocapsid interacts with viral RNA to initiate liquid-liquid phase separation.

Important observations

The study findings reveal that two separate and distinct double-stranded RNA motifs are recognized by two RNA-binding domains (RBD1 and RBD2) of SARS-CoV-2 nucleocapsid to promote liquid-liquid phase separation. Specifically, RBD1 interacts with transcription-regulating sequence (TRS) in an RNA structure-dependent manner, and RBD2 interacts with double-stranded RNA in a sequence-independent manner. The interaction between RBD2 and double-stranded regulates the LCST behavior of nucleocapsid. Collectively, these interactions are vital for specifying the temperature required for liquid-liquid phase separation.

Importantly, the patterning of protein – RNA interactions regulate liquid-liquid phase separation to specify the rate of condensation, the efficiency of RNA translation, and genome condensation.

Nucleocapsid – RNA interactions in SARS-CoV-2 infection

The study findings provide a mechanism by which nucleocapsid triggers a cascade of events required to establish SARS-CoV-2 infection.

Upon viral entry into host cells, the nucleocapsid protein dissociates from the condensed genome because of low initial protein concentration. This leads to the initiation of protein translation. With the progression of infection, a shift from translation to single genome packaging occurs because of nucleocapsid accumulation. This subsequently stops the production of non-structural proteins while sparing sub-genomic RNAs that are required for the production of nucleocapsid and other structural proteins. The presence of high affinity nucleocapsid binding sites at genome ends may facilitate liquid-liquid phase separation-mediated circularization to induce single genome packaging.  

Within the double membrane vesicles, complexes of RNA and nucleocapsid form, and the condensed genome gradually matures to form virions. The recruitment of nucleocapsid to low affinity genome sites is driven by high protein concentration within the vesicles.

Although the length of double-stranded RNA is crucial for RBD2 – RNA interaction, the primary sequence specificity of the stem-loops is not vital for the interaction. Extreme differences in stem-loop lengths can alter the temperature encoding behavior, with 20 – 24 nucleotide double-stranded RNA inducing liquid-liquid phase separation at 37°C and addition double-stranded RNA reducing the temperature to as low as 25°C.

Based on the study findings, the most efficient binding sites for RBD2 are the well-structured stem loops at the genome end. Such interactions facilitate liquid-liquid phase separation at normal body temperature (37°C). Binding to RBD2 at 37°C facilitates the dissolution of the RBD2 dimerization domain, and temperature-dependent unfolding of this domain is vital to the LCST behavior of nucleocapsid protein.

Furthermore, the study findings indicate that specific pattering of the genomic RNA sequence or structure determines nucleocapsid interactions to promote RNA genome condensation or packaging. Although nucleocapsid readily forms large droplets in cells, the genome is instead packed into regularly-spaced protein – RNA complexes that may be arrested in coarsening.

Study significance

The study reveals that the sequence and structural specificity of double-stranded RNA determines the liquid-liquid phase separation behavior of SARS-CoV-2 nucleocapsid protein. Moreover, the study demonstrates how complex interactions between viral protein and RNA determine the kinetics, properties, and temperature at which protein droplets can form.

*Important Notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha. (2021, June 16). Scientists reveal the mechanism of liquid-liquid phase separation of SARS-CoV-2 nucleocapsid. News-Medical. Retrieved on July 29, 2021 from

  • MLA

    Dutta, Sanchari Sinha. "Scientists reveal the mechanism of liquid-liquid phase separation of SARS-CoV-2 nucleocapsid". News-Medical. 29 July 2021. <>.

  • Chicago

    Dutta, Sanchari Sinha. "Scientists reveal the mechanism of liquid-liquid phase separation of SARS-CoV-2 nucleocapsid". News-Medical. (accessed July 29, 2021).

  • Harvard

    Dutta, Sanchari Sinha. 2021. Scientists reveal the mechanism of liquid-liquid phase separation of SARS-CoV-2 nucleocapsid. News-Medical, viewed 29 July 2021,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
SARS-CoV-2 spike-specific antibodies induced in breast milk by COVID-19 vaccines